Concord Biotech (BOM:543960) EBIT per Share : ₹42.34 (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech EBIT per Share?

Concord Biotech's EBIT per Share for the three months ended in Sep. 2024 was ₹12.47. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹42.34.

During the past 12 months, the average EBIT per Share Growth Rate of Concord Biotech was 5.00% per year. During the past 3 years, the average EBIT per Share Growth Rate was 8.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Concord Biotech's EBIT per Share or its related term are showing as below:

BOM:543960' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 8.4 Med: 12.25 Max: 16.1
Current: 8.4

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Concord Biotech was 16.10% per year. The lowest was 8.40% per year. And the median was 12.25% per year.

BOM:543960's 3-Year EBIT Growth Rate is ranked better than
58.09% of 1248 companies
in the Biotechnology industry
Industry Median: 2.8 vs BOM:543960: 8.40

Concord Biotech's EBIT for the three months ended in Sep. 2024 was ₹1,304 Mil.

Concord Biotech EBIT per Share Historical Data

The historical data trend for Concord Biotech's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech EBIT per Share Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

EBIT per Share

20.49

29.96

23.23

31.21

39.68

Concord Biotech Quarterly Data
	Mar20	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial							10.56	9.90	12.35	7.63	12.47

Concord Biotech EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Concord Biotech's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

	EBIT per Share		(A: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	4151.169	/	104.616
=	39.68

Concord Biotech's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1304.308	/	104.635
=	12.47

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹42.34

Concord Biotech (BOM:543960) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Concord Biotech EBIT per Share Related Terms

Thank you for viewing the detailed overview of Concord Biotech's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.

Concord Biotech Headlines

No Headlines